Measuring fetal adipose tissue using 3D water-fat magnetic resonance imaging: a feasibility study

Reduced adipose tissue in growth-restricted fetuses using quantitative analysis of magnetic resonance images

OBJECTIVES

Fat-water MRI can be used to quantify tissues' lipid content. We aimed to quantify fetal third trimester normal whole-body subcutaneous lipid deposition and explore differences between appropriate for gestational age (AGA), fetal growth restriction (FGR), and small for gestational age fetuses (SGAs).

METHODS

We prospectively recruited women with FGR and SGA-complicated pregnancies and retrospectively recruited the AGA cohort (sonographic estimated fetal weight [EFW] ≥ 10th centile). FGR was defined using the accepted Delphi criteria, and fetuses with an EFW < 10th centile that did not meet the Delphi criteria were defined as SGA. Fat-water and anatomical images were acquired in 3 T MRI scanners. The entire fetal subcutaneous fat was semi-automatically segmented. Three adiposity parameters were calculated: fat signal fraction (FSF) and two novel parameters, i.e., fat-to-body volume ratio (FBVR) and estimated total lipid content (ETLC = FSF*FBVR). Normal lipid deposition with gestation and differences between groups were assessed.

RESULTS

Thirty-seven AGA, 18 FGR, and 9 SGA pregnancies were included. All three adiposity parameters increased between 30 and 39 weeks (p < 0.001). All three adiposity parameters were significantly lower in FGR compared with AGA (p ≤ 0.001). Only ETLC and FSF were significantly lower in SGA compared with AGA using regression analysis (p = 0.018-0.036, respectively). Compared with SGA, FGR had a significantly lower FBVR (p = 0.011) with no significant differences in FSF and ETLC (p ≥ 0.053).

CONCLUSIONS

Whole-body subcutaneous lipid accretion increased throughout the third trimester. Reduced lipid deposition is predominant in FGR and may be used to differentiate FGR from SGA, assess FGR severity, and study other malnourishment pathologies.

CLINICAL RELEVANCE STATEMENT

Fetuses with growth restriction have reduced lipid deposition than appropriately developing fetuses measured using MRI. Reduced fat accretion is linked with worse outcomes and may be used for growth restriction risk stratification.

KEY POINTS

• Fat-water MRI can be used to assess the fetal nutritional status quantitatively. • Lipid deposition increased throughout the third trimester in AGA fetuses. • FGR and SGA have reduced lipid deposition compared with AGA fetuses, more predominant in FGR.

Pregnancies complicated by gestational diabetes and fetal growth restriction: an analysis of maternal and fetal body composition using magnetic resonance imaging

INTRODUCTION

Maternal body composition may influence fetal body composition.

OBJECTIVE

The objective of this pilot study was to investigate the relationship between maternal and fetal body composition.

METHODS

Three pregnant women cohorts were studied: healthy, gestational diabetes (GDM), and fetal growth restriction (FGR). Maternal body composition (visceral adipose tissue volume (VAT), subcutaneous adipose tissue volume (SAT), pancreatic and hepatic proton-density fat fraction (PDFF) and fetal body composition (abdominal SAT and hepatic PDFF) were measured using MRI between 30 to 36 weeks gestation.

RESULTS

Compared to healthy and FGR fetuses, GDM fetuses had greater hepatic PDFF (5.2 [4.2, 5.5]% vs. 3.2 [3, 3.3]% vs. 1.9 [1.4, 3.7]%, p = 0.004). Fetal hepatic PDFF was associated with maternal SAT (r = 0.47, p = 0.02), VAT (r = 0.62, p = 0.002), and pancreatic PDFF (r = 0.54, p = 0.008). When controlling for maternal SAT, GDM increased fetal hepatic PDFF by 0.9 ([0.51, 1.3], p = 0.001).

CONCLUSION

In this study, maternal SAT, VAT, and GDM status were positively associated with fetal hepatic PDFF.

The mysterious values of adipose tissue density and fat content in infants: MRI-measured body composition studies

Adipose tissue is a type of connective tissue composed of closely packed adipocytes with collagenous and elastic fibers. These adipocytes store triglycerides at a high percentage and the estimate of this amount is important for the calculation of body fat mass. For example, magnetic resonance imaging (MRI) measures adipose tissue volume, but adipose tissue density (fat content percentage and density) is required to calculate fat mass. However, in previously published studies, the conversion factor for white adipose tissue density varies from study to study. This paper aimed to investigate the different adipose tissue densities used as conversion factors to clarify differences between studies. Furthermore, we include a new proposal for adipose tissue density and fat content of infants based on the results of recent water-fat MRI studies. IMPACT: Magnetic resonance imaging (MRI) is one of the methods used to measure body composition in infants and the inherent density of tissue/organs is needed in order to calculate the mass of target organs and tissues. The conversion factor used for white adipose tissue density currently varies from study to study. This article includes a new recommendation for the adipose tissue density and fat content of infants based on the results of recent water-fat MRI studies.

The Fat Fraction Percentage of White Adipose Tissue at various Ages in Humans: An Updated Review

We recently reported the fat fraction percentage of white adipose tissue in adolescents and adults measured by the water-fat separation method, but there was limited discussion about the change in adipose tissue fat fraction with growth. The purpose of this updated review was to examine the fat content of white (subcutaneous) adipose tissue during the process from birth to adulthood by adding the latest available data. A relevant database was searched through November 2020. Nineteen studies were included. We found that calculated mean values of fat fraction percentage in white adipose tissue were 72.2% in neonates, 87.2% in children, and 87.4% in adults. In contrast, fat fraction percentage of truncal white adipose tissue in the fetuses was from 10% to 24% (29 and 34 wk of gestational age, respectively). Our results suggest that the fat fraction percentage of white adipose tissue may not undergo large changes during the process from birth to adulthood (neonates = 72.2%, children = 87.2%, adults = 87.4%), which was different from the results of a study utilizing a biopsy. The mean value and range of fat fraction percentages for children over 7 years old were especially similar to adults. Further, the fat fraction percentage for neonates was relatively close to the results of children and adults. At the moment, the characteristics of the changes in fat fraction percentage of adipose tissue from birth to preschool children are unclear and future research is needed to clarify this issue.

Water-fat magnetic resonance imaging of adipose tissue compartments in the normal third trimester fetus

BACKGROUND

Assessment of fetal adipose tissue gives information about the future metabolic health of an individual, with evidence that the development of this tissue has regional heterogeneity.

OBJECTIVE

To assess differences in the proton density fat fraction (PDFF) between fetal adipose tissue compartments in the third trimester using water-fat magnetic resonance imaging (MRI).

MATERIALS AND METHODS

Water-fat MRI was performed in a 1.5-T scanner. Fetal adipose tissue was segmented into cheeks, thorax, abdomen, upper arms, forearms, thighs and lower legs. PDFF and R2* values were measured in each compartment.

RESULTS

Twenty-eight women with singleton pregnancies were imaged between 28 and 38 weeks of gestation. At 30 weeks' gestation (n=22), the PDFF was statistically different between the compartments (P<0.0001), with the highest PDFF in cheeks, followed by upper arms, thorax, thighs, forearms, lower legs and abdomen. There were no statistical differences in the rate of PDFF change with gestational age between the white adipose tissue compartments (P=0.97). Perirenal brown adipose tissue had a different PDFF and R2* compared to white adipose tissue, while the rate of R2* change did not significantly change with gestational age between white adipose tissue compartments (P=0.96).

CONCLUSION

Fetal adipose tissue accumulates lipids at a similar rate in all white adipose tissue compartments. PDFF variances between the compartments suggest that accumulation begins at different gestational ages, starting with cheeks, followed by extremities, trunk and abdomen. Additionally, MRI was able to detect differences in the PDFF between fetal brown adipose tissue and white adipose tissue.

Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World Congress

Advanced imaging techniques are enhancing research capacity focussed on the developmental origins of adult health and disease (DOHaD) hypothesis, and consequently increasing awareness of future health risks across various subareas of DOHaD research themes. Understanding how these advanced imaging techniques in animal models and human population studies can be both additively and synergistically used alongside traditional techniques in DOHaD-focussed laboratories is therefore of great interest. Global experts in advanced imaging techniques congregated at the advanced imaging workshop at the 2019 DOHaD World Congress in Melbourne, Australia. This review summarizes the presentations of new imaging modalities and novel applications to DOHaD research and discussions had by DOHaD researchers that are currently utilizing advanced imaging techniques including MRI, hyperpolarized MRI, ultrasound, and synchrotron-based techniques to aid their DOHaD research focus.

Quantification of 1.5 T T1 and T2 * Relaxation Times of Fetal Tissues in Uncomplicated Pregnancies

BACKGROUND

Despite its many advantages, experience with fetal magnetic resonance imaging (MRI) is limited, as is knowledge of how fetal tissue relaxation times change with gestational age (GA). Quantification of fetal tissue relaxation times as a function of GA provides insight into tissue changes during fetal development and facilitates comparison of images across time and subjects. This, therefore, can allow the determination of biophysical tissue parameters that may have clinical utility.

PURPOSE

To demonstrate the feasibility of quantifying previously unknown T₁ and T₂ ^* relaxation times of fetal tissues in uncomplicated pregnancies as a function of GA at 1.5 T.

STUDY TYPE

Pilot.

POPULATION

Nine women with singleton, uncomplicated pregnancies (28-38 weeks GA).

FIELD STRENGTH/SEQUENCE

All participants underwent two iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL-IQ) acquisitions at different flip angles (6° and 20°) at 1.5 T.

ASSESSMENT

Segmentations of the lungs, liver, spleen, kidneys, muscle, and adipose tissue (AT) were conducted using water-only images and proton density fat fraction maps. Driven equilibrium single pulse observation of T₁ (DESPOT₁ ) was used to quantify the mean water T₁ of the lungs, intraabdominal organs, and muscle, and the mean water and lipid T₁ of AT. IDEAL T₂ ^* maps were used to quantify the T₂ ^* values of the lungs, intraabdominal organs, and muscle.

STATISTICAL TESTS

F-tests were performed to assess the T₁ and T₂ ^* changes of each analyzed tissue as a function of GA.

RESULTS

No tissue demonstrated a significant change in T₁ as a function of GA (lungs [P = 0.89]; liver [P = 0.14]; spleen [P = 0.59]; kidneys [P = 0.97]; muscle [P = 0.22]; AT: water [P = 0.36] and lipid [P = 0.14]). Only the spleen and muscle T₂ ^* showed a significant decrease as a function of GA (lungs [P = 0.67); liver [P = 0.05]; spleen [P < 0.05]; kidneys [P = 0.70]; muscle [P < 0.05]).

DATA CONCLUSION

These preliminary data suggest that the T₁ of the investigated tissues is relatively stable over 28-38 weeks GA, while the T₂ ^* change in spleen and muscle decreases significantly in that period.

LEVEL OF EVIDENCE

3 TECHNICAL EFFICACY STAGE: 2.

MRI-Derived Fetal Weight Estimation in the Midpregnancy Fetus: A Method Comparison Study

OBJECTIVES

The aim of this study was to compare the standard ultrasound (US) estimated fetal weight (EFW) and MRI volume-derived methods for the midtrimester fetus.

METHODS

Twenty-five paired US and MRI scans had the EFW calculated (gestational age [GA] range = 20-26 weeks). The intra- and interobserver variability of each method was assessed (2 operators/modality). A small sub-analysis was performed on 5 fetuses who were delivered preterm (mean GA 29 +3 weeks) and compared to the actual birthweight.

RESULTS

Two MRI volumetry EFW formulae under-measured compared to US by -10.9% and -14.5% in the midpregnancy fetus (p < 0.001) but had excellent intra- and interobserver agreement (intraclass correlation coefficient = 0.998 and 0.993). In the preterm fetus, the mean relative difference (MRD) between the MRI volume-derived EFW (MRI-EFW) and actual expected birthweight (at the scan GA) was -13.7% (-159.0 g, 95% CI: -341.7 to 23.7 g) and -17.1% (-204.6 g, 95% CI: -380.4 to -28.8 g), for the 2 MRI formulae. The MRD was smaller for US at 5.3% (69.8 g, 95% CI: -34.3 to 173.9).

CONCLUSIONS

MRI-EFW results should be interpreted with caution in midpregnancy. Despite excellent observer agreement with MRI volumetry, refinement of the EFW formula is needed in the second trimester, for the small and for the GA and preterm fetus to compensate for lower fetal densities.

The application of in utero magnetic resonance imaging in the study of the metabolic and cardiovascular consequences of the developmental origins of health and disease

Observing fetal development in utero is vital to further the understanding of later-life diseases. Magnetic resonance imaging (MRI) offers a tool for obtaining a wealth of information about fetal growth, development, and programming not previously available using other methods. This review provides an overview of MRI techniques used to investigate the metabolic and cardiovascular consequences of the developmental origins of health and disease (DOHaD) hypothesis. These methods add to the understanding of the developing fetus by examining fetal growth and organ development, adipose tissue and body composition, fetal oximetry, placental microstructure, diffusion, perfusion, flow, and metabolism. MRI assessment of fetal growth, organ development, metabolism, and the amount of fetal adipose tissue could give early indicators of abnormal fetal development. Noninvasive fetal oximetry can accurately measure placental and fetal oxygenation, which improves current knowledge on placental function. Additionally, measuring deficiencies in the placenta’s transport of nutrients and oxygen is critical for optimizing treatment. Overall, the detailed structural and functional information provided by MRI is valuable in guiding future investigations of DOHaD.